Literature DB >> 15888022

Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury.

Melissa J Burne-Taney1, Naoko Yokota-Ikeda, Hamid Rabb.   

Abstract

B and T cells have been implicated in the pathogenesis of renal ischemia reperfusion injury (IRI); however, it is unknown if B and T cells interact in early injury responses, as seen in adaptive immune responses. Recent evidence has shown that B-cell deficient and T-cell deficient mice are partially protected from renal IRI. Renal IRI was induced in recombinase activating gene (RAG)-1 deficient mice, which lack both B and T cells. RAG-1 deficient mice from two different background strains were not protected from renal IRI. Adoptive transfer of either B or T cells into RAG-1 deficient mice led to a significant protection of renal injury, which was independent of effects on neutrophil trafficking. Neutrophil depletion in RAG-1 deficient mice did not protect from IRI. While deficiency of either B or T cells reduced IRI, combined lack of both is not protective. These results demonstrate that complex interactions between B and T cells are likely occurring in kidney IRI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888022     DOI: 10.1111/j.1600-6143.2005.00815.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  33 in total

Review 1.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

2.  B Cells in Transplantation of Rat, Mouse, and Man.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

Review 3.  Ischemia-reperfusion and immediate T cell responses.

Authors:  Yanfei Huang; Hamid Rabb; Karl L Womer
Journal:  Cell Immunol       Date:  2007-10-17       Impact factor: 4.868

4.  Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury.

Authors:  Kengo Furuichi; Ji-Liang Gao; Richard Horuk; Takashi Wada; Shuichi Kaneko; Philip M Murphy
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 5.  Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

Review 6.  Inflammation in acute kidney injury.

Authors:  Gilbert R Kinsey; Li Li; Mark D Okusa
Journal:  Nephron Exp Nephrol       Date:  2008-09-18

7.  The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury.

Authors:  Song Rong; Joon-Keun Park; Torsten Kirsch; Hideo Yagita; Hisaya Akiba; Olaf Boenisch; Hermann Haller; Nader Najafian; Antje Habicht
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

Review 8.  The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.

Authors:  Veena Roberts; Bo Lu; Siddharth Rajakumar; Peter J Cowan; Karen M Dwyer
Journal:  Purinergic Signal       Date:  2012-11-29       Impact factor: 3.765

9.  Resident macrophages reprogram toward a developmental state after acute kidney injury.

Authors:  Jeremie M Lever; Travis D Hull; Ravindra Boddu; Mark E Pepin; Laurence M Black; Oreoluwa O Adedoyin; Zhengqin Yang; Amie M Traylor; Yanlin Jiang; Zhang Li; Jacelyn E Peabody; Hannah E Eckenrode; David K Crossman; Michael R Crowley; Subhashini Bolisetty; Kurt A Zimmerman; Adam R Wende; Michal Mrug; Bradley K Yoder; Anupam Agarwal; James F George
Journal:  JCI Insight       Date:  2019-01-24

10.  Natural IgM Switches the Function of Lipopolysaccharide-Activated Murine Bone Marrow-Derived Dendritic Cells to a Regulatory Dendritic Cell That Suppresses Innate Inflammation.

Authors:  Peter I Lobo; Kailo H Schlegel; Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Binru Wang; Hong Ye; Thomas F Tedder; Gilbert R Kinsey; Mark D Okusa
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.